MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Cardiovascular autonomic dysfunction, depression and cognitive disorders in Parkinson’s disease patients

    A. Guekht, M. Lebedeva, G. Popov, A. Yakovlev, O. Davidov (Moscow, Russian Federation)

    Objective: The aim of the study was to determine the relationship between depression, cognitive disorders and autonomic regulation of the cardiovascular system in patients with…
  • 2017 International Congress

    Parkinson Disease-Associated Polyneuropathy: A Biomarker of Disease Severity?

    M. Rosso, A. Merola, A. Romagnolo, C. Comi, A. Fasano, M. Zibetti, R. Lopez-Castellanos, D. Cocito, L. Lopiano, A. Espay (Cincinnati, OH, USA)

    Objective: Objective: We sought to examine the association between Parkinson disease (PD) associated polyneuropathy (PD-PNP) and levodopa dose, age, and disease duration in a cross-sectional,…
  • 2017 International Congress

    Profiling the Non Motor Symptoms burden in Parkinson’s disease patients in Nigeria

    T. Farombi, A. Ogunniyi (Ibadan, Nigeria)

    Objective: To determine the frequency of Non- motor symptoms (NMS) burden using the non-motor symptoms questionnaire (NMSQuest). Background: Over the years, motor manifestations were more associated with…
  • 2017 International Congress

    Olfaction and gustation in patients with Parkinson’s Disease

    A. Tautscher-Basnett, V. Tomantschger, M. Freimueller (Hermagor, Austria)

    Objective: This study investigates smell and taste function in patients with Parkinson’s Disease (PD). Background: Up to 90% of patients with PD suffer from olfactory…
  • 2017 International Congress

    A global survey of the use and linguistic translation of the NMSQuest and NMSScale: implications for non-motor studies in Parkinson’s disease

    A. Sauerbier, L. Klingelhoefer, R. Banerjee, S. Diaconu, R. Erro, T. Farombi, S. Gangadharan, A. Macerollo, L. Chahine, O. Jitkritsadakul, R. Biundo, M. Grilo, H. Dafsari, G. Pagano, F. Niccolini, N. Titova (London, United Kingdom)

    Objective: To collect details of linguistic validations and translations of the non-motor symptoms questionnaire (NMSQuest) and non-motor symptoms scale (NMSScale) globally.  Background: The patient completed…
  • 2017 International Congress

    Weight loss in Parkinson’s disease (PD)

    K. Khalid, D. Linsky, H. Khan, S. Pradhan, A. Chatterjee (Reading, United Kingdom)

    Objective: To quantify and assess weight loss in older patients with PD attending a Movement disorders clinic Background: Patients with Parkinson’s disease often lose weight…
  • 2017 International Congress

    Videoendoscopy study of swallowing in Parkinson’s disease

    J. Fukae, Y. Tsuboi, S. Fujioka, G. Umemoto (Fukuoka, Japan)

    Objective: We make a hypothesis that dysphagia of anti-parkinsonian drugs may be associated with motor fluctuation, especially delay on. In this study, we compared videoendoscopy…
  • 2017 International Congress

    Speech Markers Estimate Motor Severity and Global Cognition in Parkinson’s Disease

    K. Smith, T. Quatieri, J. Williamson (Worcester, MA, USA)

    Objective: To utilize free speech characteristics to develop markers of motor and cognitive status in Parkinson’s disease (PD). Background: Vocal biomarkers based on speech volume,…
  • 2017 International Congress

    Impulse control disorder and associated clinical factors in drug-naïve Parkinson’s disease.

    D. Gupta, M. Marano, S. Fahn (New York, NY, USA)

    Objective: To investigate various clinical factors associated with Impulse Control Disorders (ICD) in Parkinson's disease (PD) patients who have never been exposed to Dopamine Replacement…
  • 2017 International Congress

    Relationship between sleep profiles and clinical features in Parkinson’s disease

    Y.-Y. Lin, R.-S. Chen, C.-S. Lu, Y.-Z. Huang, Y.-H. Weng, T.-H. Yeh, W.-Y. Lin, J. Hung (Taoyuan, Taiwan)

    Objective: To document the prevalence of sleep disturbance and excessive daytime sleepiness (EDS) in Taiwanese Parkinson’s disease (PD) patients and to identify the risk factors…
  • « Previous Page
  • 1
  • …
  • 1380
  • 1381
  • 1382
  • 1383
  • 1384
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley